论文部分内容阅读
目的观察舒利迭联合孟鲁司特治疗小儿哮喘的临床疗效。方法回顾性分析方城县人民医院2010年3月至2011年3月98例小儿哮喘患者的临床资料,将其随机设为对照组和治疗组,在常规综合治疗基础上对照组加用孟鲁司特,治疗组在对照组基础上联合舒利迭,2周后观察两组临床效果。结果治疗后对照组总有效率为67.3%,治疗组总有效率为87.8%,两组比较差异有统计学意义(P<0.05)。结论舒利迭联合孟鲁司特治疗小儿哮喘疗效好,复发率低,值得临床推广。
Objective To observe the clinical efficacy of seretide and montelukast in the treatment of pediatric asthma. Methods The clinical data of 98 cases of pediatric asthma in Fangcheng County People’s Hospital from March 2010 to March 2011 were retrospectively analyzed. They were randomly divided into control group and treatment group. On the basis of conventional comprehensive treatment, Stef, the treatment group on the basis of the control group combined with seretide, two weeks after the two groups were observed clinical effect. Results After treatment, the total effective rate of the control group was 67.3%, and the total effective rate of the treatment group was 87.8%. There was significant difference between the two groups (P <0.05). Conclusion The combination of seretide and montelukast in pediatric asthma has good curative effect and low recurrence rate, which deserves clinical promotion.